Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Acebutolol hydrochloride |
Is a |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acebutolol measurement |
Component |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acebutolol adverse reaction |
Causative agent (attribute) |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely acebutolol 100 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely acebutolol 400 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acebutolol+diuretic (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acebutolol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acebutolol hydrochloride |
Is a |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acebutolol measurement |
Component |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acebutolol adverse reaction |
Causative agent (attribute) |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to acebutolol |
Causative agent (attribute) |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely acebutolol 100 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acebutolol 200mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely acebutolol 400 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acebutolol+diuretic (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acebutolol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing acebutolol and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to acebutolol |
Causative agent (attribute) |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acebutolol 100 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acebutolol 100 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acebutolol 200mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acebutolol 200mg capsule (substance) |
Has basis of strength substance (attribute) |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acebutolol 400 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acebutolol 400 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acebutolol hydrochloride |
Is modification of (attribute) |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acebutolol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acebutolol 200mg capsule (substance) |
Has precise active ingredient |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acebutolol 400 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acebutolol 100 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acebutolol- and hydrochlorothiazide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Acebutolol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acebutolol and hydrochlorothiazide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Acebutolol and hydrochlorothiazide only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only acebutolol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acebutolol (as acebutolol hydrochloride) 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acebutolol (as acebutolol hydrochloride) 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acebutolol (as acebutolol hydrochloride) 100 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acebutolol (as acebutolol hydrochloride) 200 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely acebutolol (as acebutolol hydrochloride) 400 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
acébutolol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |